Feedback

X
Advances in Multiple Sclerosis Research—Series I

Advances in Multiple Sclerosis Research—Series I

0 Ungluers have Faved this Work
Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 34 times via unglue.it ebook links.
  1. 18 - pdf (CC BY) at res.mdpi.com.

Keywords

  • adult-onset
  • agonist peptide
  • alemtuzumab
  • altered peptide ligands
  • antibodies against GluR3 peptide
  • antibody detection
  • antigen-specific immunotherapies
  • antigen-specific immunotherapy
  • Astrocytes
  • Autoimmune Diseases
  • autoimmune encephalitis
  • Autoimmunity
  • B cell receptor
  • biomarker
  • bupropion
  • Carriers
  • cellular immunity
  • Central nervous system
  • cerebral blood flow
  • chloroquine
  • clinical outcome
  • clinical outcomes
  • clinical phenotype
  • cognitive impairment
  • conformational analysis
  • conjugation
  • cranial nerve-VI palsy
  • craniopharyngioma
  • delivery methods
  • Dendritic Cells
  • Diagnosis
  • diagnostic markers
  • disease-modifying treatments
  • drug delivery nanosystems
  • EAE
  • early-onset
  • ELISA
  • experimental autoimmune encephalomyelitis
  • fampridine
  • fractionated stereotactic radiation treatments
  • free light chains
  • Graphite/SiO2 electrode
  • gut microbiome
  • gut–brain axis
  • HPLC
  • Human Leucocyte Antigens
  • immune modulation
  • immune thrombocytopenic purpura
  • Immunogenetics
  • Immunoglobulins
  • Immunomodulation
  • immunotherapeutics
  • Immunotherapy
  • Inflammation
  • intracortical facilitation
  • kappa
  • Lipids
  • major depression
  • mannan
  • MBP83–99 peptide
  • medicine
  • memory T cells
  • Metagenomics
  • Microglia
  • MOG35-55
  • molecular dynamic
  • monoclonal antibodies
  • MS
  • MS drugs
  • Multiple Sclerosis
  • multivalency
  • myelin basic protei
  • myelin oligodendrocyte glycoprotein
  • myelin peptides
  • N-glucosylated peptide epitopes
  • Nanoparticles
  • Nanotechnology
  • neurodegeneration
  • neuroimaging
  • neuropsychological assessment
  • NMR spectroscopy
  • NOE-constraints
  • oligodendrocytes
  • oxidative
  • peptide
  • Peptides
  • plasma exchange
  • Polymers
  • positron emission tomography
  • Probiotics
  • proteolipid protein
  • S-adenosylmethionine
  • Sample Size
  • short intracortical inhibition
  • sphenoid sinusitis
  • ST285
  • Streptococcus thermophilus
  • T cell receptor
  • tDCS
  • Tetraspanins
  • Therapeutics
  • tolerance
  • Tolerance induction
  • tolerogenic vaccines
  • trimolecular complex
  • TSPAN32
  • Vaccine
  • Vaccines
  • vitamin D3
  • Voltammetry
  • walking disability
  • Yoga

Links

DOI: 10.3390/books978-3-03943-948-5

Editions

edition cover

Share

Copy/paste this into your site: